Immunologic effects of dioxin: New results from Seveso and comparison with other studies

Environmental Health Perspectives

Volumn 110, Issue 12, 2002, Pages 1169-1173

  Baccarelli, Andrea ^a,b   Mocarelli, Paolo ^c   Patterson Jr , Donald G ^d   Bonzini, Matteo ^b   Pesatori, Angela C ^b   Caporaso, Neil ^a   Landi, Maria Teresa ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Complement; Dioxin; Environmental disasters; Immune system; Immunoglobulins; Tetrachlorodibenzodioxin

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTIBIOTIC AGENT; DIOXIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGE; ANTIBIOTIC RESISTANCE; BLOOD LEVEL; CANCER INCIDENCE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD INTAKE; GEOGRAPHY; HUMAN; HUMORAL IMMUNITY; IMMUNOCYTOTOXICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; ITALY; LIVESTOCK; LYMPHATIC SYSTEM TUMOR; MALE; MULTIPLE REGRESSION; NONHUMAN; OCCUPATIONAL ACCIDENT; POLLUTION; POULTRY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SMOKING; VIRUS RESISTANCE;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0036913475     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.021101169     Document Type: Review

References (38)

1. Bäsecke J, Griesinger F, Trumper L, Brittinger G. 2002. Leukemia-and lymphoma-associated genetic aberrations in healthy individuals. Ann Hematol 81:64-75.
2. Bertazzi PA, Consonni D, Bachetti S, Rubagotti M, Baccarelli A, Zocchetti C, et al. 2001. Health effects of dioxin exposure: a 20-year mortality study. Am J Epidemiol 153:1031-1044.
3. Bertazzi PA, Di Domenico A. 1994. Chemical, environmental, and health aspects of the Seveso, Italy accident. In: Dioxins and Health (Schecter A, ed). New York:Plenum Press, 587-632.
4. Birnbaum LS, Tuomisto J. 2000. Non-carcinogenic effects of TCDD in animals. Food Addit Contam 17:275-288.
5. Colosio C, Corsini E, Barcellini W, Maroni M. 1999. Immune parameters in biological monitoring of pesticide exposure: current knowledge and perspectives. Toxicol Lett 108:285-295.
6. Dragan YP, Schrenk D. 2000. Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion. Food Addit Contam 17:289-302.
7. Halperin W, Vogt R. Sweeney MH, Shopp G. Fingerhut M, Petersen M. 1998. Immunological markers among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 55:742-749.
8. Heinzel FP. 2000. Antibodies. In: Principles and Practice of Infectious Diseases (Mandell GL, Bennett JE, Dolin R, eds). 5th ed. Philadelphia:Churchill Livingstone, 45-67.
9. Hoffman RE, Stehr-Green PA, Webb KB, Evans RG, Knutsen AP, Schramm WF, et al. 1986. Health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. JAMA 255:2031-2038.
10. Holsapple MP, Synder NK, Wood SC, Morris DL. 1991. A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence:1991 upate. Toxicology 69:219-255.
11. IARC. 1997. Polychlorinated Dibenzo-para-Dioxins and Polychlorinated Dibenzofurans. IARC Monogr Eval Carcinog Risks Hum 69.
12. Jansing PJ, Korff R. 1994. Blood levels of 2,3,7,8-tetra-chlorodibenzo-p-dioxin and gamma-globulins in a follow-up investigation of employees with chloracne. J Dermatol Sci 8:91-95.
13. Jennings AM, Wild G, Ward JD, Ward AM. 1988. Immunological abnormalities 17 years after accidental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Br J Ind Med 45:701-704.
14. Jung D, Berg PA, Edler L. Ehrenthal W, Fenner D, Flesch-Janys D, et al. 1998. Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners. Environ Health Perspect 106(suppl 2):689-695.
15. Kerkvliet NI. 1995. Immunological effects of chlorinated dibenzo-p-dioxins. Environ Health Perspect 103 (suppl 9):47-53.
16. Kerkvliet NI. 2002. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int Immunopharmacol 2:277-291.
17. Landi MT, Consonni D, Patterson DG Jr, Needham LL, Lucier G, Brambilla P, et al. 1998. 2,3,7,8-Tetrachlorodibenzo-p-dioxin plasma levels in Seveso 20 years after the accident. Environ Health Perspect 106:273-277.
18. Landi MT, Needham LL, Lucier G, Mocarelli P, Bertazzi PA, Caporaso N. 1997. Concentrations of dioxin 20 years after Seveso [Letter]. Lancet 349:1811.
19. Li CY, Sung FC. 1999. A review of the healthy worker effect in occupational epidemiology. Occup Med 49:225-229.
20. Løvik M, Johansen HR, Gaarder PI, Becher G, Aaberge IS, Gdynia W, et al. 1996. Halogenated organic compounds and the human immune system: preliminary report on a study in hobby fishermen. Arch Toxicol 18(suppl):15-20.
21. Marth E, Sixl W, Bencko V, Medwed M, Lapajne S, Voncina E, et al.1995. People on the garbage dumps of Cairo: a toxicological in vivo model? Cent Eur J Public Health 3:154-157.
22. Michalek JE, Ketchum NS, Check IJ. 1999. Serum dioxin and immunologic response in veterans of Operation Ranch Hand. Am J Epidemiol 149:1038-1046.
23. Nagayama J, Tsuji H, Iida T, Hirakawa H, Matsueda T, Ohki M. 2001. Effects of contamination level of dioxins and related chemicals on thyroid hormone and immune response systems in patients with "Yusho". Chemosphere 43:1005-1010.
24. Neubert R, Maskow L, Triebig G, Broding HC, Jacob-Muller U, Helge H, et al. 2000. Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system: 3. Plasma immunoglobulins and cytokines of workers with quantified moderately-increased body burdens. Life Sci 66:2123-2142.
25. Nohara K, Fujimaki H, Tsukumo S, Inouye K, Sone H. Tohyama C. 2002. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57BI/6 mice. Toxicology 172:49-58.
26. Ott MG, Zober A, Germann C. 1994. Laboratory results for selected target organs in 138 individuals occupationally exposed to TCDD. Chemosphere 29:2423-2437.
27. Patterson DG Jr, Hampton L, Lapeza CR Jr, Belser WT, Green V, Alexander L, et al. 1987. High-resolution gas chromatographic/high-resolution mass spectrometric analysis of human serum on a whole-weight and lipid basis for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Anal Chem 59:2000-2005.
28. Pocchiari F, Silano V, Zampieri A. 1979. Human health effects from accidental release of tetrachlorodibenzo-p-dioxin (TCDD) at Seveso, Italy. Ann NY Acad Sci 320:311-320.
29. Ravel R. 1995. Serum proteins. In: Clinical Laboratory Medicine. St. Louis:Mosby-Year Book, 342-368.
30. Rothman KJ, Greenland S. 1998. Prevention of confounding. In: Modern Epidemioloy (Rothman KJ, Greenland S, eds). 2nd ed. Philadelphia:Lippincott-Raven, 143-145.
31. Sirchia GG. 1982. Exposure to TCDD: immunologic effects. In: PLans for Clinical and Epidemiologic Follow-up after Area-wide Chemical Contamination (Dardanoni L, Miller RW, eds). Washington, DC:National Academy Press, 234-266.
32. Sulentic CE, Holsapple MP, Kaminski NE. 2000. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J Pharmacol Exp Ther 295:705-716.
33. Thomas L. 1990. Quantitative immunochemical plasma protein analysis by immunonephelometry and immnoturbidimetry. Lab Med 14:313-320.
34. Vorderstrasse BA, Steppan LB, Silverstone AE, Kerkvliet NI. 2001. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol Appl Pharmacol 171:157-164.
35. Webb KB, Evans RG, Knutsen AP, Roodman ST, Roberts DW, Schramm WF, et al. 1989. Medical evaluation of subjects with known body levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Toxicol Environ Health 28:183-193.
36. WHO-ECEH. 2000. Consultation on assessment of the health risk of dioxins; re-evaluation of the tolerable daily intake (TDI): executive summary. Food Addit Contam 17:223-240.
37. Ziegler FP. 1994. Cancer in the immunocompromised host. In: Basic and Clinical Immunology (Stites DP, Terr AI, Parslow TG, eds). 8th ed. Philadelphia:Lippincott-Raven, 578-587.
38. Zober A, Ott MG, Messerer P. 1994. Morbidity follow up study of BASF employees expose to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident. Occup Environ Med 51:479-486.